{"id":821627,"date":"2025-03-04T16:15:01","date_gmt":"2025-03-04T21:15:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/"},"modified":"2025-03-04T16:15:01","modified_gmt":"2025-03-04T21:15:01","slug":"absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/","title":{"rendered":"Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">VANCOUVER, Wash. and NEW YORK, March  04, 2025  (GLOBE NEWSWIRE) &#8212; Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates and financial and operating results for the fourth quarter and full year 2024 after market close on Tuesday, March 18, 2025.<\/p>\n<p align=\"justify\">Absci management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its business developments, financial and operating results, and outlook.<\/p>\n<p align=\"justify\">Live audio of the webcast will be available on the company\u2019s investor relations website at: investors.absci.com. The webcast will be archived and available for replay after the event.<\/p>\n<p align=\"justify\">\n        <strong>About Absci<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SP2aDi9wi9Kpr6qKJ1Q4mKbnXgLnxQYKGVAiW_00hu880UJ4yivXG5P3JuMyl-SkIu8eBcUjwAC1S_sIYxMmjg==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <u>Absci<\/u><br \/>\n        <\/a> is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=i8Ir3O1j-Gx4uPT5FztZij5C_Fzob0h1vIa8MmN-aFVEF54If8lbEwGvlvUN_Hj0W2DlVi1Y6-g29sYVi9cRcSFQT9gXPsboGadsl0Mz69cMM9J8AAVZrml8tv5lYWE4\" rel=\"nofollow\" target=\"_blank\"><u>Integrated Drug Creation<\/u><\/a>\u2122 platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to train, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed candidates to wet lab-validated candidates in as little as six weeks. Absci\u2019s headquarters is in Vancouver, WA, with our AI Research Lab in New York City and an Innovation Center in Zug, Switzerland. Visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7iAOO7zMUVUQGgfe3dGGuh9UkzGToY-fE5epe78z0z129CRIyhFZcxp46qvwDJOOAe02vlapcnbTV9I18Sxv4A==\" rel=\"nofollow\" target=\"_blank\"><u>www.absci.com<\/u><\/a> and follow us on LinkedIn (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VoBVX_V4JWHhGjhRyJiXBkEozlfyZTmC-GF1i3CtGkJrVUTgeoRZJR4ZsL4Sm8tNDJ0Wk0cUU1kPx7oSabHYUZFEbuqw2xQgKtH8mh1eLL0=\" rel=\"nofollow\" target=\"_blank\"><u>@absci<\/u><\/a>), X (Twitter) (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gAHkgDPMUO94-Uj9OzU39ix-j7dW5CSHmWv1OSir0fqnjoVuAqQ1D_C2jWHpfYrwwQ1Dqcv2IWXjyuyzSwDzEA==\" rel=\"nofollow\" target=\"_blank\"><u>@Abscibio<\/u><\/a>), and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=n-pW9_RuT-lJVrfgTWcqnbQ6VRQ7yf6RKDpd8iaDTt5CqlefAXrG7KXOkcD05weUwyrBV1nI2LX98gLshC5Udg==\" rel=\"nofollow\" target=\"_blank\"><u>YouTube<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>Alex Khan<br \/>VP, Finance &amp; Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2YWySjEJIdRm_WlK-7RGUu_RS7TWK3U_EPJ7uZsSKsTN3ayb6GKID_mPwT1jqCNvychZrkaUm7omRcu5IWr6ZcjEyzg9ixYjrmevJ5_8dA8=\" rel=\"nofollow\" target=\"_blank\">investors@absci.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Media Contact\u00a0<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OHRQ0NEYTiyf0OlzWXiBjwoiryJgFbPPPC3_kb6hZfryfYNAfCUe9n1HR_XuVZrW-oR_6U_ovcdxFpK8iWNSVg==\" rel=\"nofollow\" target=\"_blank\">press@absci.com<\/a>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Nzg5NyM2NzUwNzA0IzIyMTAwODA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDJhZTlkNzctZDVhNC00MDg2LTg5NjMtMzA0NjM3YzZlNDg4LTEyMjE2MzM=\/tiny\/ABSCI-Corporation.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, Wash. and NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) &#8212; Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates and financial and operating results for the fourth quarter and full year 2024 after market close on Tuesday, March 18, 2025. Absci management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its business developments, financial and operating results, and outlook. Live audio of the webcast will be available on the company\u2019s investor relations website at: investors.absci.com. The webcast will be archived and available for replay after the event. About Absci Absci is a data-first generative AI drug creation company that &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-821627","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, Wash. and NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) &#8212; Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates and financial and operating results for the fourth quarter and full year 2024 after market close on Tuesday, March 18, 2025. Absci management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its business developments, financial and operating results, and outlook. Live audio of the webcast will be available on the company\u2019s investor relations website at: investors.absci.com. The webcast will be archived and available for replay after the event. About Absci Absci is a data-first generative AI drug creation company that &hellip; Continue reading &quot;Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-04T21:15:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Nzg5NyM2NzUwNzA0IzIyMTAwODA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025\",\"datePublished\":\"2025-03-04T21:15:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\\\/\"},\"wordCount\":275,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Nzg5NyM2NzUwNzA0IzIyMTAwODA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\\\/\",\"name\":\"Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Nzg5NyM2NzUwNzA0IzIyMTAwODA=\",\"datePublished\":\"2025-03-04T21:15:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Nzg5NyM2NzUwNzA0IzIyMTAwODA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Nzg5NyM2NzUwNzA0IzIyMTAwODA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/","og_locale":"en_US","og_type":"article","og_title":"Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025 - Market Newsdesk","og_description":"VANCOUVER, Wash. and NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) &#8212; Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates and financial and operating results for the fourth quarter and full year 2024 after market close on Tuesday, March 18, 2025. Absci management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its business developments, financial and operating results, and outlook. Live audio of the webcast will be available on the company\u2019s investor relations website at: investors.absci.com. The webcast will be archived and available for replay after the event. About Absci Absci is a data-first generative AI drug creation company that &hellip; Continue reading \"Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-04T21:15:01+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Nzg5NyM2NzUwNzA0IzIyMTAwODA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025","datePublished":"2025-03-04T21:15:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/"},"wordCount":275,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Nzg5NyM2NzUwNzA0IzIyMTAwODA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/","name":"Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Nzg5NyM2NzUwNzA0IzIyMTAwODA=","datePublished":"2025-03-04T21:15:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Nzg5NyM2NzUwNzA0IzIyMTAwODA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Nzg5NyM2NzUwNzA0IzIyMTAwODA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-fourth-quarter-and-full-year-2024-financial-and-operating-results-on-march-18-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/821627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=821627"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/821627\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=821627"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=821627"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=821627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}